<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05003414</url>
  </required_header>
  <id_info>
    <org_study_id>P02.014.26</org_study_id>
    <nct_id>NCT05003414</nct_id>
  </id_info>
  <brief_title>The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study</brief_title>
  <official_title>A Prospective, Multicentre, International, Post-marketing, Longitudinal, Observational Cohort Study to Monitor the Performances of GMK Sphere Cementless Knee Prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta International SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta International SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Post-Marketing Surveillance study of GMK Sphere cementless knee prosthesis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2032</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate</measure>
    <time_frame>10 years</time_frame>
    <description>Kaplan Meier method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome</measure>
    <time_frame>Preop and 1, 2, 5, 10 years postop</time_frame>
    <description>Knee Society Score (KSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported outcome</measure>
    <time_frame>1, 2, 5, 10 years postop</time_frame>
    <description>Forgotten Joint Score (FJS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic performance of the implants</measure>
    <time_frame>Immediately postop + 1, 2, 5, 10 years postop</time_frame>
    <description>Presence of radiolucencies, migration, loosening, subsidence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Intraop + Immediately postop + 1, 2, 5, 10 years postop</time_frame>
    <description>Intraoperative and postoperative adverse events</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Arthritis</condition>
  <condition>Traumatic Arthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Poly-arthritis</condition>
  <condition>Avascular Necrosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GMK Sphere cementless Knee Replacement</intervention_name>
    <description>Performance of Total Knee Arthroplasty (TKA) with GMK Sphere cementless Knee Replacement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring Total Knee Arthroplasty and who are suitable to receive Medacta GMK&#xD;
        Sphere cementless Knee Replacement will be proposed to take part to the current post-market&#xD;
        surveillance study during their pre-operative visit.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A disabled or severely disabled joint as a result of arthritis, traumatic arthritis,&#xD;
             rheumatoid arthritis, poly-arthritis or avascular necrosis&#xD;
&#xD;
          -  Patients between the age of 18 and 80 at the time of consent&#xD;
&#xD;
          -  Listed for total knee replacement surgery.&#xD;
&#xD;
          -  Patients who are willing and able to give informed written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Progressive local or systemic infection&#xD;
&#xD;
          -  Muscular loss, neuromuscular disease or vascular deficiency of the affected limb,&#xD;
             making the operation unjustifiable&#xD;
&#xD;
          -  Severe instability secondary to advance destruction of condralar structures or loss of&#xD;
             integrity of the medial or lateral ligament&#xD;
&#xD;
          -  Those whose prospects for a recovery to independent mobility would be compromised by&#xD;
             known coexistent, medical problems&#xD;
&#xD;
          -  Patient whose BMI exceeds 40&#xD;
&#xD;
          -  Any case not described in the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Marchetti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Saint Vincent de Paul</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denise Falcone</last_name>
    <phone>+41916966060</phone>
    <email>falcone@medacta.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mara Colombo</last_name>
    <phone>+41916966060</phone>
    <email>colombo@medacta.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique Saint Vincent de Paul</name>
      <address>
        <city>Bourgoin-Jallieu</city>
        <zip>38300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Marchetti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique du Parc</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilan Klebaner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Civils de Colmar</name>
      <address>
        <city>Colmar</city>
        <zip>68000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ziad Sader, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique des Acacias</name>
      <address>
        <city>Cucq</city>
        <zip>62780</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier Caenen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Tour</name>
      <address>
        <city>Meyrin</city>
        <zip>CH-1217</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Alves, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 6, 2021</study_first_submitted>
  <study_first_submitted_qc>August 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

